tradingkey.logo

Sironax Grants Novartis Exclusive Option To Acquire Its Brain Delivery Platform

ReutersJul 9, 2025 12:21 PM

- Novartis AG NOVN.S:

  • SIRONAX: GRANTS NOVARTIS EXCLUSIVE OPTION TO ACQUIRE ITS BRAIN DELIVERY PLATFORM WHILE RETAINING RIGHTS TO ADVANCE SELECTED THERAPEUTIC ASSETS

  • SIRONAX: SIRONAX IS ELIGIBLE TO RECEIVE UP TO $175 MILLION IN UPFRONT AND NEAR-TERM PAYMENTS UNDER AGREEMENT

  • SIRONAX: UNDER AGREEMENT, NOVARTIS TO EVALUATE BDM PLATFORM WITHIN OPTION PERIOD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI